• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

史蒂文斯-约翰逊综合征后的假性黑色素瘤

Pseudomelanomas Following Stevens-Johnson Syndrome.

作者信息

Ardakani Nima Mesbah, Tiwari Shevya M, Wood Benjamin A

机构信息

*Department of Anatomical Pathology, PathWest Laboratory Medicine, QEII Medical Centre, Perth, Australia; †School of Pathology and Laboratory Medicine, University of Western Australia, Perth, Australia; and ‡Department of Dermatology, Charles Gairdner Hospital, Perth, Australia.

出版信息

Am J Dermatopathol. 2017 Nov;39(11):853-856. doi: 10.1097/DAD.0000000000000886.

DOI:10.1097/DAD.0000000000000886
PMID:28763334
Abstract

In this report, we present a novel case of pseudomelanoma, similar to that seen in a recurrent/traumatized nevus, in pre-existing nevi in a 36-year-old man a few months after recovering from an episode of severe Stevens-Johnson syndrome. The mechanism responsible for the atypical transformation of these nevi is likely the release of cytokines and growth factors in the microenvironment during the repair/regeneration process. It is important to be aware of this phenomenon, and specific inquiry about potential recent blistering skin disorder in addition to the other causes of trauma should be made when dealing with cases of pseudomelanoma to avoid misdiagnosis.

摘要

在本报告中,我们介绍了一例36岁男性在严重史蒂文斯-约翰逊综合征发作恢复数月后,其原有痣出现类似复发性/创伤性痣所见的假黑色素瘤新病例。这些痣发生非典型转变的机制可能是修复/再生过程中微环境中细胞因子和生长因子的释放。认识到这一现象很重要,在处理假黑色素瘤病例时,除了询问其他创伤原因外,还应特别询问近期是否有潜在的水疱性皮肤病,以避免误诊。

相似文献

1
Pseudomelanomas Following Stevens-Johnson Syndrome.史蒂文斯-约翰逊综合征后的假性黑色素瘤
Am J Dermatopathol. 2017 Nov;39(11):853-856. doi: 10.1097/DAD.0000000000000886.
2
Molecular testing to differentiate melanoma from benign nevi: The gold standard limitation.
J Am Acad Dermatol. 2016 Oct;75(4):849-850. doi: 10.1016/j.jaad.2016.06.038.
3
Differentiation of melanoma and benign nevi by fluorescence in-situ hybridization.荧光原位杂交鉴别黑色素瘤与良性痣。
Melanoma Res. 2011 Oct;21(5):426-30. doi: 10.1097/CMR.0b013e328347ee1d.
4
Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.用于区分痣样黑色素瘤与有丝分裂活跃痣的荧光原位杂交技术。
Am J Surg Pathol. 2009 Dec;33(12):1783-8. doi: 10.1097/PAS.0b013e3181ba6db6.
5
Eruptive melanocytic nevi after Stevens-Johnson syndrome.史蒂文斯-约翰逊综合征后的发疹性黑素细胞痣
J Am Acad Dermatol. 1997 Aug;37(2 Pt 2):337-9.
6
Melanoma-specific marker expression in skin biopsy tissues as a tool to facilitate melanoma diagnosis.皮肤活检组织中黑色素瘤特异性标志物的表达可作为辅助黑色素瘤诊断的工具。
J Invest Dermatol. 2010 Jul;130(7):1887-92. doi: 10.1038/jid.2010.61. Epub 2010 Apr 1.
7
The recurrent nevus phenomenon: a history of challenge, controversy, and discovery.复发性痣现象:一个充满挑战、争议和发现的历史。
Arch Pathol Lab Med. 2011 Jul;135(7):842-6. doi: 10.5858/2010-0429-RAR.1.
8
Molecular testing for melanocytic tumors: a practical update.黑素细胞肿瘤的分子检测:实用更新
Histopathology. 2022 Jan;80(1):150-165. doi: 10.1111/his.14570.
9
Number, size, and histopathology of nevi in Utah kindreds.犹他家族中痣的数量、大小及组织病理学特征。
Cytogenet Cell Genet. 1992;59(2-3):167-9. doi: 10.1159/000133234.
10
Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.深部穿透性痣样交界性肿瘤:一类具有恶性潜能且细胞遗传学正常的特殊含混不清黑素细胞肿瘤亚型。
Eur J Dermatol. 2014 Sep-Oct;24(5):594-602. doi: 10.1684/ejd.2014.2393.

引用本文的文献

1
Recurrent Nevus Phenomenon Developing within a Keloid.瘢痕疙瘩内出现的复发性痣现象。
Dermatopathology (Basel). 2023 Jun 30;10(3):201-206. doi: 10.3390/dermatopathology10030028.
2
Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN).严重皮肤不良反应表皮坏死松解症(EN)的临床和发病方面。
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):1957-1971. doi: 10.1111/jdv.16339. Epub 2020 May 15.